PDCD4 and lung carcinoma: PDCD4 levels were also decreased in primary patient tumor samples from lung cancer [8], hepatocellular carcinoma [10], breast carcinoma [11], colon cancer [12,13], glioma [14], pancreatic cancer [15] and esophageal carcinoma [16].